Matinas BioPharma Investor Presentation Deck slide image

Matinas BioPharma Investor Presentation Deck

28 Experienced Leadership Team EXECUTIVE TEAM Jerome D. Jabbour, J.D. Chief Executive Officer ReliantⓇ PHARMACEUTICALS James Ferguson, M.D. Chief Medical Officer The Medicines AMGEN Company AstraZeneca Thomas Hoover, MBA Chief Business Officer MILLENDO Sunovion THERAPEUTICS gsk Keith Kucinski, CPA, MBA Chief Financial Officer PAR barr PHARMACEUTICAL Pharmanticals (5 Theresa Matkovits, Ph.D. Chief Development Officer nps pharmaceuticals NOVARTIS The Medicines Company Hui Liu, Ph.D., MBA Chief Technology Officer Allergan. Alcon Segirus A CSL COMPANY COPYRIGHT MATINAS BIOPHARMA 2024 BOARD OF DIRECTORS Eric Ende, M.D., MBA Chairman of the Board Herbert Conrad Director James Scibetta Director Kathryn Corzo Director Natasha Giordano Director Matthew Wikler, M.D., MBA Director Jerome D. Jabbour, J.D. CEO genzyme MERRILL A SANOFI COMPANY PHARMASSET Roche ImmunelD bit.bio THE CELL CODING COMPANY A BANK OF AMERICA COMPANY MAVERICK THERAPEUTICS Celldex therapeutics ReliantⓇ PHARMACEUTICALS Takeda PACIRA PHARMACEUTICALS, INC. SANOFI PLX Xanodyne PHARMA INC. pharmaceuticals, inc. ReliantⓇ PHARMACEUTICALS Medicines FDA Company MATINAS BIOPHARMA
View entire presentation